Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Francesca Barone Insider Profile
4 Followers
Francesca Barone, CSO at Candel Therapeutics, holds 124.21K shares in Candel Therapeutics (Ticker: CADL). Most recently, Francesca Barone Sold $13,673 shares of Candel Therapeutics on Jan 10, 2025 for an estimated value of 112.26K.
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-39.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Francesca Barone's holdings
Insider Roles
CSO
Roles that Francesca Barone holds in companies
Most Profitable Insider Trade
The most profitable trade made by Francesca Barone
Francesca Barone's Trading History
List of latest transactions for each holding click on a transaction to see Francesca Barone's performance on stock
You May Also Like
Francesca Barone insider profile FAQ
What is the percentage of profitable transactions made by Francesca Barone?
The percentage of profitable transactions made by Francesca Barone is 0%.
What is the average return per transaction made by Francesca Barone?
The average return per transaction made by Francesca Barone is -39.40%.
What stocks does Francesca Barone hold?
Francesca Barone holds: CADL stocks.
What was Francesca Barone’s latest transaction?
Francesca Barone latest transaction was an Informative Sell of $112.26K.
What was Francesca Barone's most profitable transaction?
Francesca Barone’s most profitable transaction was an Informative Sell of CADL stock on January 10, 2025. The return on the trade was 0.00%.
What is Francesca Barone's role in Candel Therapeutics?
Francesca Barone's role in Candel Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.